Allogeneic autophagosome-enriched composition for the treatment of disease
Document Type
Patent
Publication Date
10-23-2013
Abstract
A composition, comprising: an enriched population of autophagosomes derived from a non-small cell lung carcinoma cell line, and wherein the enriched population of autophagosomes includes: one or more toll-like receptor agonists; one or more tumor antigens; and one or more damage-associated molecular pattern molecules. In this way, an off-the-shelf vaccine may be available to be administered in order to stimulate a targeted immune response in patients bearing different tumor types.
Clinical Institute
Cancer
Specialty/Research Institute
Allergy & Immunology
Specialty/Research Institute
Oncology
Location
United States
Assignee
UbiVac, LLC (Portland, OR); Providence Health & Services-Oregon (Portland, OR)
Family ID
50485552
Serial Number
14/061,135
Tech ID
12-03-INV
COinS
